A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC
Clinical trial NCT03904823 · UNKNOWN
Trial details
- NCT number
- NCT03904823
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-25
- Primary completion
- 2022-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.